Dr. Borris Rosnay Galani Tietcheu
My Social Links

Dr. Borris Rosnay Galani Tietcheu

Lecturer/Researcher
University of Ngaoundere, Cameroon


Highest Degree
Ph.D. in Pharmacology and Toxicology from University of Yaounde I, Yaounde, Cameroon

Share this Profile

Area of Interest:

Pharmacology and Toxicology
100%
Phytochemical Studies
62%
Liver Function
90%
Chemical Hepatitis
75%
Viral Hepatitis
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
18
Abstracts
1

Selected Publications

  1. Tietcheu, B.R.G., C.N. Babai and A. Ngakou, 2022. Seroprevalence, risk factors and impact of dengue fever/hepatitis B coinfection on liver function parameters in Cameroonian patients. Clin. Exp. Hepatol., 8: 161-169.
    CrossRef  |  Direct Link  |  
  2. Kafache, D., M. Deli, B.R.T. Galani, A.N. Agume, A.A. Bouba and N.Y. Njintang, 2022. Physicochemical and in vitro antioxidant properties of juice and cake filters from Carissa edulis Vahl fruits. J. Explor. Res. Pharmacol., 7: 133-144.
    CrossRef  |  Direct Link  |  
  3. Djasrabe, A.K., B.R.T. Galani, M.M. Ali, F.H. Yandai, B. Nadlaou, M. Habkreo and N.Y. Njintang, 2022. Serological evidence of hepatitis B and E and dengue coinfection in Chadian patients and impact on lipidemia profile. Int. J. Hepatol., 10.1155/2022/8373061.
    CrossRef  |  Direct Link  |  
  4. Galani, B.R.T., V.B.A. Owona, R.J.G. Temdie, K. Metzger and M.A. Amougou, et al., 2021. In silico and in vitro screening of licensed antimalarial drugs for repurposing as inhibitors of hepatitis E virus. In Silico Pharmacol., 10.1007/s40203-021-00093-y.
    CrossRef  |  Direct Link  |  
  5. Galani, B.R.T., V.B.A. Owona, R.J.G. Temdie, K. Metzger and M.A. Amougou et al., 2021. In silico and in vitro screening of licensed antimalarial drugs for repurposing as inhibitors of hepatitis E virus. In Silico Pharmacol., Vol. 9. 10.1007/s40203-021-00093-y.
    CrossRef  |  Direct Link  |  
  6. Ayissi, O.V.B., R.T.G. Borris and M.P. Fewou, 2021. In Silico identification of apigenin and narcissin (food-flavonoids) as potential targets against SARS-CoV-2 viral proteins: Comparison with the effect of remdesivir. J. Clin. Anesth. Pain Manag., 5: 214-223.
    CrossRef  |  Direct Link  |  
  7. Ayissi, O.V.B., G.R.T. Borris and M.P. Fewou, 2021. In silico identification of apigenin and narcissin (food-flavonoids) as potential targets against SARS-CoV-2 viral proteins: Comparison with the effect of remdesivir. J. Clin. Anesthesia Pain Manage., 5: 214-223.
    CrossRef  |  Direct Link  |  
  8. Valansa A., B.R.T. Galani, P.D.D. Chuisseu, A.T. Tsamo, V.B.A. Owona and N.Y. Njintang, 2020. Natural limonoids protect mice from alcohol-induced liver injury. Journal of Basic and Clinical Physiology and Pharmacology 10.1515/jbcpp-2019-0271 http://dx.doi.org/10.1515/jbcpp-2019-0271.
    CrossRef  |  
  9. Galani, B.R.T., D.W. Mapouokam, F.B.N. Simo, H. Mohamadou, P.D.D. Chuisseu, N.Y. Njintang and P.F. Moundipa, 2020. Investigation of dengue–malaria coinfection among febrile patients consulting at Ngaoundere Regional Hospital, Cameroon. J. Med. Virol., 93: 3350-3361.
    CrossRef  |  Direct Link  |  
  10. Galani B.R.T., B.A. Owona, D.P. D. Chuisseu, E. Machewere, C.B.N. Ngantchouko and P.F. Moundipa, 2020. Hepatoprotective activity of leptadenia hastata (asclepiadaceae) on acetaminophen-induced toxicity in mice: in vivo study and characterization of bioactive compounds through molecular docking approaches. BioMed Research International 2020: 1-15.
    CrossRef  |  Direct Link  |  
  11. Djibersou, D., B.R.G. Tietcheu, P.D. Chuisseu and N. Njintang, 2020. Anti-oxidant and anti-inflammatory potential of aqueous extracts of leaves, barks and roots of Bixa orellana L. (Bixaceae) on acetaminophen-induced liver damage in mice. Avicenna J. Phytomed., 10: 428-439.
    CrossRef  |  Direct Link  |  
  12. Chuisseu P., B.R.G. Tietcheu, N.C.K. Younang, A.F. Kouam, B.F.N. Simo, A.N. Tchana, K.Seron, J. Dubuisson, G. Tiegs, J. Kouamouo and P.F. Moundipa, 2020. Aqueous extracts of desmodium adscendens (fabaceae) possess in vitro antioxidant properties and protect hepatocytes from carbone tetrachloride-induced injury and hepatitis c virus infection. Investigational Medicinal Chemistry and Pharmacology 3: 1-10.
    CrossRef  |  Direct Link  |  
  13. Galani, B.R.T., R. Njouom and P.F. Moundipa, 2016. Hepatitis C in Cameroon: What is the progress from 2001 to 2016? J. Transl. Int. Med., 4: 162-169.
    Direct Link  |  
  14. Galani, B.R.T., M.E. Sahuc, G. Sass, F.N. Njayou and C. Loscher et al., 2016. Khaya grandifoliola C.DC: A potential source of active ingredients against hepatitis C virus in vitro. Arch. Virol., 161: 1169-1181.
    CrossRef  |  Direct Link  |  
  15. Galani, B.R.T., M.E. Sahuc, F. Njayou, G. Deloison and P. Mkounga et al., 2015. Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro. Front. Microbiol., Vol. 6. 10.3389/fmicb.2015.00488.
    CrossRef  |  Direct Link  |  
  16. Tietcheu, B.R.G., G. Sass, N.F. Njayou, P. Mkounga, G. Tiegs and F.P. Moundipa, 2014. Anti-hepatitis c virus activity of crude extract and fractions of entada africana in genotype 1b replicon systems. Am. J. Chin. Med., 42: 853-868.
    CrossRef  |  Direct Link  |  
  17. Njayou, F.N., T.B.R. Galani, T.B. Ngadjui and F.P. Moundipa, 2013. Hepatoprotective activity of three Cameroonian medicinal plants against oxidative damages induced by paracetamol and CCl4 in primary rat hepatocytes. Int. J. Pharm. Photon, 104: 306-314.